Recombinant Collagen Skin Booster
Human-like recombinant collagen protocols with HA/PDRN support
About This Treatment
Recombinant collagen boosters, increasingly discussed in Korea and China, combine human-like recombinant collagen fragments with HA, PDRN, peptides or succinate to support dermal repair.
Product differences are substantial; injectable grade, sterility and regulatory status must be checked. Brand-level RCT evidence remains limited.
Mechanism of Action
Recombinant collagen fragments may provide ECM substrate/signals, while HA hydrates and PDRN/peptides support repair and fibroblast biology.
Indications
Expected Results
Series of 3-5 sessions are assessed for dryness, firmness, pores and fine lines, focusing on skin quality and recovery support rather than major contour change.
Clinical Evidence
Risks & Side Effects
Erythema, swelling, itching, bruising, allergy and nodules may occur. Avoid non-injectable or research-use products.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition